To assist dermatologists and the patients they serve, the IPC is collecting information from around the world on coronavirus and psoriasis. If you have a resource on COVID-19 and psoriasis to add, please submit it to IPC.
The COVID-19 pandemic has been a significant concern, and vaccination has been crucial worldwide in its combat.
A research group led by Catherine Smith from St John’s Institute of Dermatology described humoral and cellular immunity.
Psoriasis experts worldwide give their take on the most important COVID-19 publications.
Videos on current research and treatment strategies regarding psoriasis and COVID-19 from IPC congress symposia and webinars presented by IPC experts.
PsoProtect is an international registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. The registry seeks to improve our understanding of how factors such as immunomodulator therapies and comorbidities impact outcomes to COVID-19 in psoriasis. This information will inform clinicians when assessing risk and treating COVID-19 in patients with psoriasis.